Albemarle Corp sell UBS Group AG
Start price
12.07.25
/
50%
€60.75
Target price
12.07.26
€48.75
Performance (%)
13.10%
Price
20:06
€68.71
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 13.10%. This prediction currently runs until 12.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | 13.256% | 13.256% |
| iShares Core DAX® | 1.061% | -0.453% |
| iShares Nasdaq 100 | 2.615% | 4.747% |
| iShares Nikkei 225® | 5.693% | 9.002% |
| iShares S&P 500 | 1.433% | 3.156% |
Comments by UBS_Group_AG for this prediction
In the thread Albemarle Corp diskutieren
Albemarle Corporation (NYSE: ALB) was downgraded by analysts at UBS Group AG from a "hold" rating to a "sell" rating. They now have a $57.00 price target on the stock.
Ratings data for ALB provided by MarketBeat
Stopped prediction by UBS_Group_AG for Albemarle Corp
Albemarle Corp
Start price
Target price
Perf. (%)
€196.80
18.05.23
18.05.23
€208.46
18.05.24
18.05.24
-38.27%
19.05.24
19.05.24
